Is there really room for anti-rheumatic drugs in the treatment of COVID-19?

Scand J Rheumatol. 2020 Sep;49(5):412-413. doi: 10.1080/03009742.2020.1765413. Epub 2020 Jul 28.

Authors

E G Favalli¹, F Ingegnoli^{1

2}, M Biggioggero¹, R Caporali^{1

2}

Affiliations

¹ Division of Clinical Rheumatology, ASST Gaetano Pini-CTO Institute , Milan, Italy.
² Department of Clinical Sciences and Community Health, Research Center for Adult and Pediatric Rheumatic Diseases, University of Milan , Milan, Italy.

PMID: 32720847
DOI: 10.1080/03009742.2020.1765413

No abstract available

Publication types

Letter
Comment

MeSH terms

Adult
Antirheumatic Agents*
Betacoronavirus
COVID-19
China
Coronavirus Infections*
Humans
Inpatients
Pandemics*
Pneumonia, Viral*
Retrospective Studies
Risk Factors
SARS-CoV-2

Substances

Antirheumatic Agents